(Q71223587)
Statements
A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation (English)
T van Gelder
A H Balk
F A Jonkman
R Zietse
P Zondervan
C J Hesse
L M Vaessen
B Mochtar